These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1944373)

  • 41. International Commission for Protection Against Environmental Mutagens and Carcinogens. Two million rodent carcinogens? The role of SAR and QSAR in their detection.
    Ashby J
    Mutat Res; 1994 Feb; 305(1):3-12. PubMed ID: 7508545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantifying genotoxicity and non-genotoxicity.
    Rosenkranz HS; Ennever FK
    Mutat Res; 1988; 205(1-4):59-67. PubMed ID: 3285198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Mutagenic activity of carcinogens and other chemical agents in Salmonella typhimurium tests].
    Khudoleĭ VV; Mizgirev IV; Pliss GB
    Vopr Onkol; 1986; 32(3):73-80. PubMed ID: 3515759
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Performance of 133 compounds in the lambda prophage induction endpoint of the Microscreen assay and a comparison with S. typhimurium mutagenicity and rodent carcinogenicity assays.
    Rossman TG; Molina M; Meyer L; Boone P; Klein CB; Wang Z; Li F; Lin WC; Kinney PL
    Mutat Res; 1991 Aug; 260(4):349-67. PubMed ID: 1831244
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis and comparison of information and data recorded in carcinogenicity and genotoxicity databases.
    Romano P; Aresu O; Parodi B; Malacarne D; Castagneto G; Parodi S; Ruzzon T
    Environ Health Perspect; 1991 Dec; 96():113-20. PubMed ID: 1820252
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Salmonella typhimurium strain TA100 differentiates several classes of carcinogens and mutagens by base substitution specificity.
    Koch WH; Henrikson EN; Kupchella E; Cebula TA
    Carcinogenesis; 1994 Jan; 15(1):79-88. PubMed ID: 8293552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In silico genotoxicity and carcinogenicity prediction for food-relevant secondary plant metabolites.
    Glück J; Buhrke T; Frenzel F; Braeuning A; Lampen A
    Food Chem Toxicol; 2018 Jun; 116(Pt B):298-306. PubMed ID: 29660365
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genotoxicity and carcinogenicity studies of bronchodilators and antiasthma drugs.
    Brambilla G; Mattioli F; Robbiano L; Martelli A
    Basic Clin Pharmacol Toxicol; 2013 May; 112(5):302-13. PubMed ID: 23374861
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanistic QSAR of aromatic amines: new models for discriminating between homocyclic mutagens and nonmutagens, and validation of models for carcinogens.
    Benigni R; Bossa C; Netzeva T; Rodomonte A; Tsakovska I
    Environ Mol Mutagen; 2007 Dec; 48(9):754-71. PubMed ID: 18008355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutagenicity study of butachlor and its metabolites using Salmonella typhimurium.
    Hsu KY; Lin HJ; Lin JK; Kuo WS; Ou YH
    J Microbiol Immunol Infect; 2005 Dec; 38(6):409-16. PubMed ID: 16341341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutagenicity and carcinogenicity of tea, Camellia sinensis.
    Nagabhushan M; Sarode AV; Nair J; Amonkar AJ; D'Souza AV; Bhide SV
    Indian J Exp Biol; 1991 May; 29(5):401-6. PubMed ID: 1916936
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on genotoxicity and carcinogenicity of antibacterial, antiviral, antimalarial and antifungal drugs.
    Brambilla G; Mattioli F; Robbiano L; Martelli A
    Mutagenesis; 2012 Jul; 27(4):387-413. PubMed ID: 22228823
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The proportions of mutagens among chemicals in commerce.
    Zeiger E; Margolin BH
    Regul Toxicol Pharmacol; 2000 Oct; 32(2):219-25. PubMed ID: 11067778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of modified bacterial mutagenicity assays for the genotoxicity testing of mineral oils.
    Brooks TM; Priston RA; Wright AS; Watson WP
    Mutagenesis; 1995 Sep; 10(5):409-15. PubMed ID: 8544754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The genetic toxicity database of the National Toxicology Program: evaluation of the relationships between genetic toxicity and carcinogenicity.
    Tennant RW
    Environ Health Perspect; 1991 Dec; 96():47-51. PubMed ID: 1820276
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genotoxic and carcinogenic effects of gastrointestinal drugs.
    Brambilla G; Mattioli F; Martelli A
    Mutagenesis; 2010 Jul; 25(4):315-26. PubMed ID: 20478972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic activation of heterocyclic amines and other procarcinogens in Salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, 1B1, 2C9, 2D6, 2E1, and 3A4 and human NADPH-P450 reductase and bacterial O-acetyltransferase.
    Oda Y; Aryal P; Terashita T; Gillam EM; Guengerich FP; Shimada T
    Mutat Res; 2001 May; 492(1-2):81-90. PubMed ID: 11377247
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transformation of BALB/c-3T3 cells: V. Transformation responses of 168 chemicals compared with mutagenicity in Salmonella and carcinogenicity in rodent bioassays.
    Matthews EJ; Spalding JW; Tennant RW
    Environ Health Perspect; 1993 Jul; 101 Suppl 2(Suppl 2):347-482. PubMed ID: 8243403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Peculiarities of extraction of 6-mercaptopurine and azathioprine from aqueous saline solutions].
    Korenman IaI; Shormanov VK; Mokshina NIa; Krivosheeva OA; Klimanov DV
    Sud Med Ekspert; 2012; 55(6):38-41. PubMed ID: 23405468
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclosporin A.
    Rep Carcinog; 2004; 11():III75-6. PubMed ID: 21089843
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.